The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Rosenfeld, P. J., Moshfeghi, A. A., & Puliafito, C. A. (2005) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-20050701-14 · Cited by 904
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
MICHELS, S., ROSENFELD, P., PULIAFITO, C., MARCUS, E., & VENKATRAMAN, A. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.02.007 · Cited by 664
Blaauwgeers, H. G. T., Holtkamp, G. M., Rutten, H., Witmer, A. N., Koolwijk, P., Partanen, T. A., Alitalo, K., Kroon, M. E., Kijlstra, A., van Hinsbergh, V. W. M., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65138-3 · Cited by 520
Chen, Y., Wiesmann, C., Fuh, G., Li, B., Christinger, H. W., McKay, P., de Vos, A. M., & Lowman, H. B. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3192 · Cited by 448
Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro
Wang, Y., Fei, D., Vanderlaan, M., & Song, A. (2004) · Angiogenesis · doi:10.1007/s10456-004-8272-2 · Cited by 430
(1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080080069030 · Cited by 413
Potential Public Health Impact of Age-Related Eye Disease Study Results: AREDS Report No. 11
(2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.11.1621 · Cited by 374
Mordenti, J., Cuthbertson, R. A., Ferrara, N., Thomsen, K., Berleau, L., Licko, V., Allen, P. C., Valverde, C. R., Meng, Y. G., Fei, D. T. W., et al. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700507 · Cited by 350
(1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090090052019 · Cited by 303
Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration
Ng, E. W. M., & Adamis, A. P. (2005) · Canadian Journal of Ophthalmology · doi:10.1016/s0008-4182(05)80078-x · Cited by 273
Inhibitors of Ocular Neovascularization: Promises and Potential Problems
van Wijngaarden, P., Coster, D. J., & Williams, K. A. (2005) · JAMA · doi:10.1001/jama.293.12.1509 · Cited by 228
ROSENFELD, P., SCHWARTZ, S., BLUMENKRANZ, M., MILLER, J., HALLER, J., REIMANN, J., GREENE, W., & SHAMS, N. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.01.043 · Cited by 223
Miller, J. W. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.9.1161 · Cited by 221
Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer
Fernando, N., & Hurwitz, H. I. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)70024-4 · Cited by 111
Mordenti, J. J. (1999) · Toxicological Sciences · doi:10.1093/toxsci/52.1.101 · Cited by 78
Bevacizumab in the treatment of colorectal cancer
Mulcahy, M. F., & Benson, A. B. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.7.997 · Cited by 71
Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer
Fernando, N. H., & Hurwitz, H. I. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00124-6 · Cited by 62
Cited by
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
The Price of Sight — Ranibizumab, Bevacizumab, and the Treatment of Macular Degeneration
Steinbrook, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068185 · Cited by 255
Systemic side effects of eye drops: a pharmacokinetic perspective
Farkouh, A., Frigo, P., & Czejka, M. (2016) · Clinical Ophthalmology · doi:10.2147/opth.s118409 · Cited by 255
Bressler, S. B. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.06.045 · Cited by 205
Mini drug pump for ophthalmic use
Saati, S., Lo, R., Li, P.-Y., Meng, E., Varma, R., & Humayun, M. S. (2010) · Current Eye Research · doi:10.3109/02713680903521936 · Cited by 77
Metadata
- Authors
- Bashshur, Z. F., Bazarbachi, A., Schakal, A., Haddad, Z. A., El Haibi, C. P., & Noureddin, B. N.
- Venue
- American Journal of Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 142
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0002-9394 (ISSN-L)
- OpenAlex
- W2023523208
- Cited by
- 305
- References
- 24
- FWCI
- 45.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.